J. Quint

First name
J.
Middle name
K.
Last name
Quint
Morgan, A., Maslova, E., Kallis, C., Sinha, I., Roberts, G., Tran, T. N., et al. (2023). Short-acting β(2)-agonists and exacerbations in children with asthma in England: SABINA Junior. Erj Open Res, 9. http://doi.org/10.1183/23120541.00571-2022
View
Czira, A., Requena, G., Banks, V., Wood, R., Tritton, T., Castillo, C. M., et al. (2023). Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β(2)-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England. Int J Chron Obstruct Pulmon Dis, 18, 643-659. http://doi.org/10.2147/copd.s405498
View
Cook, S., Schmedt, N., Broughton, J., Kalra, P. A., Tomlinson, L. A., & Quint, J. K. (2023). Characterising the burden of chronic kidney disease among people with type 2 diabetes in England: a cohort study using the Clinical Practice Research Datalink. Bmj Open, 13, e065927. http://doi.org/10.1136/bmjopen-2022-065927
View
Attar-Zadeh, D., Capstick, T., Leese, D., Arnetorp, S., Rapsomaniki, E., Da Costa, K. P., et al. (2023). Healthcare costs associated with short-acting β(2)-agonists in asthma: observational UK SABINA study. Bjgp Open. http://doi.org/10.3399/bjgpo.2023.0015
View
Mulick, A. R., Henderson, A. D., Prieto-Merino, D., Mansfield, K. E., Matthewman, J., Quint, J. K., et al. (2022). Novel multimorbidity clusters in people with eczema and asthma: a population-based cluster analysis. Sci Rep, 12, 21866. http://doi.org/10.1038/s41598-022-26357-x
View
Lewer, D., Cox, S., Hurst, J. R., Padmanathan, P., Petersen, I., & Quint, J. K. (2022). Burden and treatment of chronic obstructive pulmonary disease among people using illicit opioids: matched cohort study in England. Bmj Med, 1, e000215. http://doi.org/10.1136/bmjmed-2022-000215
View
Lenoir, A., Whittaker, H., Gayle, A., Jarvis, D., & Quint, J. K. (2022). Mortality in non-exacerbating COPD: a longitudinal analysis of UK primary care data. Thorax. http://doi.org/10.1136/thorax-2022-218724
View
Whittaker, H., Nordon, C., Rubino, A., Morris, T., Xu, Y., de Nigris, E., et al. (2022). Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent postdiagnosis COPD exacerbations and mortality: EXACOS-UK health care data study. Thorax. http://doi.org/10.1136/thorax-2022-219039
View
Karsanji, U., Evans, R. A., Quint, J. K., Khunti, K., Lawson, C. A., Petherick, E., et al. (2022). Mortality associated with metabolic syndrome in people with COPD managed in primary care. Erj Open Res, 8. http://doi.org/10.1183/23120541.00211-2022
View
Whittaker, H., Van Ganse, E., Dalon, F., Nolin, M., Marrant-Micallef, C., Pison, C., et al. (2022). Differences in severe exacerbations rates and healthcare utilisation in COPD populations in the UK and France. Bmj Open Respir Res, 9. http://doi.org/10.1136/bmjresp-2021-001150
View